Publicaciones en las que colabora con MARÍA ÁNGELES VILLANÚA BERNUÉS (8)

2015

  1. Plasma Concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: Relationship to psychiatric comorbidity

    PLoS ONE, Vol. 10, Núm. 3

2001

  1. Endocannabinoides, ¿hormonas o moduladores locales?

    Avances en endocrinología comparada (Universidad de Málaga (UMA)), pp. 183-186

  2. Functional interaction between opioid and cannabinoid receptors in drug self-administration

    Journal of Neuroscience, Vol. 21, Núm. 14, pp. 5344-5350

2000

  1. Maternal exposure to the synthetic cannabinoid HU-210: Effects on the endocrine and immune systems of the adult male offspring

    NeuroImmunoModulation, Vol. 7, Núm. 1, pp. 16-26

1998

  1. CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats

    NeuroReport, Vol. 9, Núm. 15, pp. 3397-3402

  2. Characterization of the acute endocrine actions of (-)-11-hydroxy-Δ8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats

    European Journal of Pharmacology, Vol. 344, Núm. 1, pp. 77-86

  3. Maternal exposure to low doses of Δ9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring

    Pharmacology Biochemistry and Behavior, Vol. 61, Núm. 3, pp. 229-238

1997

  1. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat

    NeuroReport, Vol. 8, Núm. 2, pp. 491-496